Dipeptide Tyr-Gly and tripeptide Tyr-Gly-Gly representing the NH2-end of the Met-enkephalin molecule inhibited the GM-colony formation in clonal cultures of mouse bone marrow cells. Intermediate or COOH-terminal dipeptides Gly-Gly and Phe-Met respectively were inneffective. The suppressive effects were not abolished by opioid receptor blocking agent naloxone and only partly so by depletion of the accessory (adherent) cells. The results are congruent with idea that neuropeptides and products of their enzymatic degradation participate in the regulation of hematopoiesis.
PleuvryB.J.1991. Opioid receptors and their ligands: natural and unnatural. Br. J. Anaesth.66:370.
2.
BlalockJ.E.1994. The syntax of immune-neuroendocrine communication. Immunol. Today15:504.
3.
KnappR.J.MalatynskaE.CollinsN.FangL.WangJ.Y.HrubyV.J.RoeskeW.R. and YamamuraH.I.. 1995. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9:516.
4.
UhlG.R.ChildersS. and PasternakG.. 1994. An opiate-receptor gene family reunion. Trends Neurosci. 17:89.
5.
AshmunR.A. and LookA.T.. 1990. Metalloprotease activity of CD 13 aminopeptidase N on the surface of human myeloid cells. Blood75:462.
6.
ShippA.M. and LookA.T.. 1993. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood82:1052.
7.
KowalskiJ.1998. Imunological action of (Met-5)enkephalin fragments. Eur. J. Pharmacol.347:95.
8.
OwenD.L.MorleyJ.S.EnsorD.M. and MilesJ.B.. 1998. The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses. Neuropeptides32:1317.
9.
SizemoreR.C.DienglewiczR.L.PecuniaE. and GottliebA.A.. 1991. Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by Leu-enkephalin and related peptides. Clin. Immunol. Immunopathol.60:310.
10.
BoranicM.Krizanac-BengezL.J.GabrilovacJ.MarottiT. and BreljakD.. 1997. Enkephalins in hematopoiesis. Biomed. Pharmacother.51:29.
11.
Krizanac-BengezL.J.BoranicM.TestaN.G. and MarottiT.. 1992. Effect of enkephalins on bone marrow cells. Biomed. Pharmacother.46:367.
12.
MansourA.HovertsenM.T.TaylorL.P.WatsonS.J. and AkilH.. 1995. The cloned (, (and (receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res. 700:89.
13.
KarasuyamaH. and MelchersF.. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol.18:97.
14.
HorvatS.HorvatJ.KantociD. and VargaL.. 1989. Glicoconjugates of opioid peptides-III+. A novel regioselective synthesis of 6-O-peptidil-D-glycopiranoses using unprotected sugars. Tetrahedron45:4579.
15.
HaberstockH. and MarottiT.. 1995. The relevance of intact enkephalin molecule in predominantly (opioid receptor mediated superoxide anion release. Neuropeptides29:357.
16.
LaerumO.D.SletvoldO.BjerknesR. and PaukovitsW.R.. 1987. A synthetic hemoregulatory peptide (HP5b) inhibits human myelopoietic colony formation (CFU-GM) but not leukocyte phagocytosis in vitro. Eur. J. Haematol.39:259.
17.
LaerumO.D.AakvaagA.FrostadS.KallandT.LangenP. and MaurerH. R.. 1990. Selectivity of hemoregulatory peptide (HP5b) action in culture. Int. J. Cell Cloning8:431.
18.
WilliamsonS.A.KnightR.A.LightmanS.L. and HobbsJ.R.. 1988. Effects of beta endorphin on specific immune responses in man. Immunology65:47.
19.
MarottiT.ÄverkoV. and HroakI.. 1990. Modulation of superoxide anion release from human polymorphonuclear cells by Met- and Leu-enkephalin. Brain Behav. Immun.4:13.
20.
LangenP.SchunckH.HungerB.SchüttM. and LaerumO.D.. 1992. Adherent-cell dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer. Exp. Hematol.20:196.
21.
BonnetD.LemoineF.M.Pontvert-DelucqS.BaillouC.NajmanA. and GuigonM.. 1993. Direct and reversible inhibitory effect of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. Blood82:3307.
22.
CashmanJ.D.EavesA.C. and EavesC.J.. 1994. The tetrapeptide AcSDKP specificaly blocks the cycling of primitive normal but not leukemic progenitors in long-term cultures: evidence for an indirect mechanism. Blood84:1534.
23.
BongiornoL.UrbaniA.MariniM.GilardiE. and RodaL. G.. 1992. Hydrolysis and association of leucine enkephalin to lymphonic and erythroleukemic cell lines ñ II. Int. J. Immunopharmac.14:643.
24.
GuigonM. and BonnetD.. 1995. Inhibitory peptides in hematopoiesis. Exp. Hematol.23:477.
